LOGIN  |  REGISTER
Cue Biopharma

Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work

September 06, 2023 | Last Trade: US$15.30 0.30 2.00

SALT LAKE CITY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Great Place To Work® and Fortune magazine have named Myriad Genetics to the 2023 Fortune Best Workplaces in Health Care™ List.

The highly competitive list is based on the analysis of survey responses from over 208,000 employees from Great Place To Work Certified™ companies in the health care industry. Earlier this year, Myriad achieved the certification, and 86% of Myriad employees said the company is a great place to work – 29 percentage points higher than a typical U.S. company.

“This Fortune Best Workplaces in Health Care recognition is a testament to our commitment of inspiring a dynamic and diverse culture, where career development is prioritized, and all teammates have equal opportunity to grow and make a difference in our patients’ lives,” said Shereen Solaiman, chief people officer, Myriad Genetics. “We’re grateful for the passion, diverse talents and enthusiasm our teammates bring to the global Myriad workforce every day to help fulfill our mission of advancing the health and well-being for all.”

Great Place To Work determines its lists using its proprietary For All™ Methodology to evaluate and certify thousands of organizations in America’s largest ongoing annual workforce study, based on over 1.3 million survey responses and data from companies representing more than 7.5 million employees this year alone. Survey responses reflect a comprehensive picture of the workplace experience.

For more information about careers at Myriad, please visit: https://myriad.com/working-at-myriad/joining-the-myriad-team/.

About Myriad Genetics

Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

About the Fortune Best Workplaces in Health Care List

Great Place To Work selected the 2023 Fortune Best Workplaces in Health Care by gathering and analyzing confidential survey responses from more than 208,000 employees at Great Place To Work Certified organizations in the health care industry. Company rankings are derived from 60 employee experience questions within the Great Place To Work Trust Index™ Survey. Great Place To Work determines its lists using its proprietary For All™ Methodology to evaluate and certify thousands of organizations in America’s largest ongoing annual workforce study. This year alone, 1.3 million survey responses were received and data from companies representing more than 7.5 million employees. Read the full methodology.

About Great Place To Work®

As the global authority on workplace culture, Great Place To Work brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Its proprietary platform and For All™ Model helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified or receiving recognition on a coveted Best Workplaces™ List.

Follow Great Place To Work on LinkedIn, Twitter, and Instagram or visit greatplacetowork.com and sign up for the newsletter to learn more.

About Fortune

The Fortune mission is to change the world by making business better. We achieve that by providing trusted information, telling great stories, and building world-class communities. We measure performance by rigorous benchmarks. And we hold companies accountable. Our goal is to make Fortune a force for good through its second century and beyond. For more information, visit www.fortune.com.

Media Contact:
Glenn Farrell
(385) 318-3718
This email address is being protected from spambots. You need JavaScript enabled to view it. 
Investor Contact:
Matt Scalo
(801) 584-3532
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB